Ethyl Acetate

Ethyl Acetate

SCHEMBL6217833

CC(C)N.CCOC(C)=O

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.74
LMNA P02545 1/20 0.74
HSD17B10 Q99714 1/20 0.74
ALOX15 P16050 1/20 0.48
TSHR P16473 2/20 0.46
MGAM O43451 1/20 0.42
GAA P10253 1/20 0.42
SI P14410 1/20 0.42
MGAM2 Q2M2H8 1/20 0.42
SOAT1 P35610 1/20 0.42
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HPGD P15428 1/20 0.39
TRPA1 O75762 1/20 0.39
GLO1 Q04760 1/20 0.38
CYP1A2 P05177 1/20 0.38
GABRP O00591 2/20 0.37
GABRD O14764 2/20 0.37
GABRA1 P14867 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL5410446 0.97 ALDH1A1 (0.70) ALDH1A1LMNAHSD17B10ALOX15TSHR
Hexane SCHEMBL4837985 0.91 ALDH1A1 (0.61) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL10436092 0.87 ALDH1A1 (0.70) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL9190132 0.87 ALDH1A1 (0.70) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL18725338 0.86 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL2210248 0.86 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL17329136 0.86 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL631255 0.86 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL15420019 0.86 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL11581471 0.86 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118209665-A High-efficiency liquid phase detection method for equine ribavirin 南京海纳医药科技股份有限公司 2024-06-18 CN disclosed
US-20050159444-A1 Bicyclic unsaturated tertiary amine compounds SANKYO COMPANY, LIMITED (JP) 2005-07-21 US disclosed
EP-1541571-A1 BICYCLIC UNSATURATED TERTIARY AMINE COMPOUND Sankyo Company, Limited (JP) 2005-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050159444-A1 Bicyclic unsaturated tertiary amine compounds IL1B, IL1A, STAT6 ALDH1A1 462/4885LMNA 2656/4885HSD17B10 862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.